How to open lucrative opportunities for the Oligonucleotide Synthesis Market?

Rise in government investments and R&D expenditure in pharmaceutical & biotechnology companies, increase in use of synthesized oligonucleotides in molecular diagnostics and clinical applications, and surge in demand for high end customized oligos and upgradation in purification drive the growth of the global oligonucleotide synthesis market. However, challenging delivery of oligonucleotide drugs to specific targets and complexities associated with therapeutic oligos hinder the market growth. On the contrary, rise in focus on personalized medicines and potential in the developing economies are expected to open lucrative opportunities for the market players in the coming years.

According to the report published by Allied Market Research, Global Oligonucleotide Synthesis Market Size Was Valued at USD 51.97 billion in 2020 and is Projected to Garner USD 26.099 billion by 2030, with a registered CAGR of 17.10% from 2021 to 2030.

Download Sample Report- https://www.alliedmarketresearch.com/request-sample/8721

Top Companies Of Oligonucleotide Synthesis Market: -
Alnylam Pharmaceuticals, Inc.
Danaher Corporation
Biogen Inc.
Ionis Pharmaceuticals, Inc.
Eurofins Scientific
LGC Limited
Kaneka Corporation
Sarepta Therapeutics, Inc.
Merck KGAA
Thermo Fisher Scientific, Inc.

Global Oligonucleotide Synthesis Market Segmentation:-

BY PRODUCT

• Oligonucleotide-based drugs
• Synthesized oligonucleotides
• Reagents
• Equipment

BY APPLICATION

• Therapeutic applications
• Research applications
• Diagnostic applications

BY END USER

• Hospitals
• Pharmaceutical & biotechnology companies
• Diagnostic laboratories
• CROs and CMOs
• Academic research institutes

For Purchase Inquiry- https://www.alliedmarketresearch.com/connect-to-analyst/8721

Key Findings of the Study

• Based on product, the oligonucleotide-based drugs held the largest share in the global market in 2020.
• On the basis of application, the therapeutic application held the largest market share in 2020, and is expected to remain dominant throughout the forecast period.
• By end user, the hospitals segment held the largest market share in 2020, and is expected to remain dominant throughout the forecast period.
• Based on region, North America is expected to experience growth at the highest rate, registering a CAGR of 16.00% during the forecast period.

By Region Outlook

North America

⦁ U.S.
⦁ Canada
⦁ Mexico

Europe

⦁ UK
⦁ Germany
⦁ France
⦁ Italy
⦁ Russia
⦁ Rest of Europe

Asia-Pacific

⦁ China
⦁ Japan
⦁ India
⦁ Australia
⦁ Rest of Asia-Pacific

LAMEA

⦁ Brazil
⦁ UAE
⦁ Turkey
⦁ Saudi Arabia
⦁ Rest of LAMEA

Have Any Query? Ask Our Experts: https://www.alliedmarketresearch.com/purchase-enquiry/8721

Other Trending Report:

Medical Clothing Market: https://www.alliedmarketresearch.com/medical-clothing-market-A17602

Rheumatoid Arthritis Drugs Market: https://www.alliedmarketresearch.com/rheumatoid-arthritis-RA-drugs-market

Trauma Implants Market: https://www.alliedmarketresearch.com/trauma-implants-market-A17527

Antibiotics Market: https://www.alliedmarketresearch.com/antibiotics-market

Medical Device Affairs Outsourcing Market: https://www.alliedmarketresearch.com/medical-device-affairs-outsourcing-market-A17667

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.